Atlas Trials

Scholar Rock, Inc.

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Scholar Rock, Inc.

RecordFirmDate
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD (NCT07435129)Scholar Rock, Inc.2026-07-30
A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults (NCT07444294)Scholar Rock, Inc.2025-11-21
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy (NCT07047144)Scholar Rock, Inc.2025-09-15
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese (NCT06445075)Scholar Rock, Inc.2024-05-21
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam (NCT05156320)Scholar Rock, Inc.2022-04-14
SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON) (NCT04291079)Scholar Rock, Inc.2020-04-23
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (NCT03921528)Scholar Rock, Inc.2019-04-22

Track Scholar Rock, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.